Excel Industries Ltd
Excel Industries is engaged in manufacturing and selling of Chemicals, Pharma intermediates and Environmental products. [1]
- Market Cap ₹ 1,105 Cr.
- Current Price ₹ 879
- High / Low ₹ 1,018 / 699
- Stock P/E 109
- Book Value ₹ 815
- Dividend Yield 1.28 %
- ROCE 11.1 %
- ROE 8.19 %
- Face Value ₹ 5.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 1.08 times its book value
- Company has been maintaining a healthy dividend payout of 18.6%
- Debtor days have improved from 66.1 to 52.4 days.
Cons
- Company has a low return on equity of 12.6% over last 3 years.
- Earnings include an other income of Rs.27.0 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
316 | 384 | 416 | 482 | 435 | 446 | 582 | 825 | 702 | 749 | 1,178 | 1,090 | 819 | |
297 | 344 | 376 | 409 | 372 | 402 | 457 | 574 | 571 | 627 | 946 | 960 | 796 | |
Operating Profit | 18 | 40 | 40 | 72 | 62 | 44 | 125 | 251 | 131 | 122 | 232 | 129 | 22 |
OPM % | 6% | 10% | 10% | 15% | 14% | 10% | 21% | 30% | 19% | 16% | 20% | 12% | 3% |
19 | 4 | 4 | 7 | 2 | 9 | 3 | 4 | 8 | 8 | 14 | 9 | 27 | |
Interest | 9 | 12 | 12 | 14 | 13 | 11 | 7 | 3 | 4 | 3 | 3 | 3 | 2 |
Depreciation | 10 | 10 | 11 | 15 | 15 | 14 | 15 | 18 | 23 | 27 | 31 | 31 | 31 |
Profit before tax | 19 | 22 | 21 | 50 | 37 | 28 | 106 | 233 | 112 | 100 | 212 | 104 | 16 |
Tax % | 21% | 32% | 15% | 19% | 31% | 25% | 31% | 35% | 17% | 30% | 24% | 25% | |
15 | 15 | 17 | 41 | 25 | 21 | 73 | 152 | 93 | 70 | 160 | 78 | 10 | |
EPS in Rs | 13.46 | 13.59 | 16.03 | 34.07 | 19.53 | 16.55 | 57.71 | 120.96 | 74.36 | 55.84 | 127.41 | 62.41 | 8.07 |
Dividend Payout % | 15% | 22% | 23% | 21% | 23% | 36% | 22% | 16% | 13% | 20% | 18% | 18% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 13% |
3 Years: | 16% |
TTM: | -33% |
Compounded Profit Growth | |
---|---|
10 Years: | 18% |
5 Years: | 1% |
3 Years: | -6% |
TTM: | -92% |
Stock Price CAGR | |
---|---|
10 Years: | 28% |
5 Years: | -4% |
3 Years: | 3% |
1 Year: | 0% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 16% |
3 Years: | 13% |
Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 118 | 128 | 141 | 176 | 201 | 352 | 434 | 584 | 595 | 710 | 926 | 985 | 1,018 |
75 | 73 | 102 | 95 | 89 | 68 | 10 | 7 | 24 | 9 | 7 | 3 | 2 | |
86 | 95 | 100 | 108 | 121 | 132 | 167 | 181 | 197 | 229 | 292 | 230 | 257 | |
Total Liabilities | 284 | 302 | 349 | 384 | 418 | 559 | 618 | 779 | 823 | 953 | 1,232 | 1,225 | 1,283 |
107 | 121 | 128 | 157 | 164 | 180 | 199 | 235 | 376 | 389 | 427 | 428 | 413 | |
CWIP | 6 | 5 | 20 | 3 | 3 | 8 | 23 | 12 | 10 | 17 | 21 | 19 | 27 |
Investments | 14 | 14 | 14 | 14 | 14 | 152 | 175 | 261 | 156 | 209 | 295 | 359 | 553 |
157 | 162 | 187 | 210 | 237 | 218 | 220 | 272 | 281 | 339 | 489 | 419 | 290 | |
Total Assets | 284 | 302 | 349 | 384 | 418 | 559 | 618 | 779 | 823 | 953 | 1,232 | 1,225 | 1,283 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
15 | 28 | 13 | 44 | 46 | 35 | 120 | 135 | 110 | 90 | 109 | 127 | |
-15 | -25 | -32 | -27 | -27 | 12 | -48 | -109 | -65 | -48 | -106 | -117 | |
4 | -4 | 20 | -23 | -17 | -48 | -73 | -24 | -31 | -17 | -17 | -35 | |
Net Cash Flow | 4 | -2 | 1 | -5 | 1 | -1 | -2 | 2 | 14 | 25 | -14 | -25 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 97 | 84 | 89 | 80 | 107 | 95 | 75 | 68 | 78 | 84 | 62 | 52 |
Inventory Days | 103 | 77 | 74 | 103 | 102 | 84 | 76 | 72 | 90 | 71 | 103 | 78 |
Days Payable | 98 | 91 | 81 | 84 | 115 | 98 | 123 | 106 | 122 | 126 | 112 | 64 |
Cash Conversion Cycle | 102 | 71 | 82 | 99 | 93 | 81 | 27 | 33 | 46 | 29 | 52 | 67 |
Working Capital Days | 78 | 70 | 76 | 73 | 86 | 88 | 58 | 60 | 60 | 53 | 62 | 60 |
ROCE % | 11% | 17% | 14% | 24% | 18% | 11% | 26% | 45% | 19% | 15% | 26% | 11% |
Documents
Announcements
- Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 1d
- Closure of Trading Window 16 Apr
- Board Meeting Intimation for Notice Of Board Meeting To Be Held On 24Th May, 2024. 16 Apr
- Disclosure Under Regulation 30 Of SEBI (LODR) 5 Apr
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Products
Agrochemical intermediates: Used as intermediates in the manufacturing of various insecticides and herbicides.
Speciality Chemicals: Specialty and performance chemicals such as Phosphonates, Biocides, and Mining chemicals.
Polymer Inputs: These are used as cross-linking or branching agents for polymers like Polycarbonates, Epoxy, Polyesters, and similar systems.
Pharma APIs: APIs used in antidiabetic and anti-gout therapeutic applications. It also manufactures veterinary APIs which are used as animal feed supplements. [1] [2]